We investigated the expression of P2X 5 , P2X 7 , P2Y 1 and P2Y 2 receptor subtypes in normal human epidermis and in relation to markers of proliferation , keratinocyte di¡erentiation (cytokeratin K10 and involucrin) and markers of apoptosis (TUNEL and anticaspase-3). Using immunohistochemistry, we showed that each of the four receptors was expressed in a spatially distinct zone of the epidermis, suggesting di¡erent functional roles for these receptors. Functional studies were performed on primary cultures of human keratinocytes and on explanted rat skin, where di¡erent P2 receptor subtype agonists and antagonists were applied to cultured keratinocytes or injected subcutaneously into the skin, respectively. An increase in cell number was caused by low doses of the nonspeci¢c P2 receptor agonist ATP, the P2Y 2 receptor agonist UTP (po0.001), and the P2Y 1 receptor agonist 2MeSADP (po0.05). There was a signi¢cant decrease in cell number as a result of treatment with the P2X 5 receptor agonist ATPcS (po0.001) and the P2X 7 receptor agonist BzATP (po0.001). Suramin caused a signi¢cant block in the e¡ect of 100 lM ATP (po0.01) and 1000 lM ATP (po0.001) on cell number. These results imply that different purinergic receptors have di¡erent functional roles in the human epidermis with P2Y 1 and P2Y 2 receptors controlling proliferation, while P2X 5 and P2X 7 receptors control early di¡erentiation, terminal di¡erentiation and death of keratinocytes, respectively. Keywords: skin/purinergic receptors/apoptosis/proliferation.
receptor agonist ATP, the P2Y 2 receptor agonist UTP (po0.001), and the P2Y 1 receptor agonist 2MeSADP (po0.05). There was a signi¢cant decrease in cell number as a result of treatment with the P2X 5 receptor agonist ATPcS (po0.001) and the P2X 7 receptor agonist BzATP (po0.001). Suramin caused a signi¢cant block in the e¡ect of 100 lM ATP (po0.01) and 1000 lM ATP (po0.001) on cell number. These results imply that different purinergic receptors have di¡erent functional roles in the human epidermis with P2Y 1 and P2Y 2 receptors controlling proliferation, while P2X 5 and P2X 7 receptors control early di¡erentiation, terminal di¡erentiation and death of keratinocytes, respectively. Keywords: skin/purinergic receptors/apoptosis/proliferation. J Invest Dermatol 120: 1007^1015, 2003 A denosine triphosphate (ATP) is now recognized as an important messenger molecule for cell-cell communication, with ATP binding speci¢cally to purinergic receptors (Ralevic and Burnstock, 1998) . The majority of studies have been concerned with the short-term events that occur in neurotransmission and secretion, but there is increasing evidence that purinergic signaling can have long-term, trophic e¡ects in cell proliferation, di¡erentiation and death (Abbracchio and Burnstock, 1998) .
Purinergic receptors are classi¢ed into two groups: P1 receptors are selective for adenosine and P2 receptors are selective for adenosine 5 0 -triphosphate (ATP) and adenosine 5 0 -diphosphate (ADP), which act as extracellular signaling molecules (Burnstock, 1978) . P2 receptors are divided into two main families: P2X (ligand^gated ion channels) and P2Y (G protein-coupled receptors), based on molecular structure, transduction mechanisms and pharmacological properties (Abbracchio and Burnstock, 1994) . Seven subtypes of P2Y receptors have been described (King and Burnstock, 2002) , and seven subtypes of P2X receptors are recognized (Khakh et al, 2001) .
There is growing evidence that ATP may act as an important local messenger in the skin, particularly the epidermis. Functional roles in the regulation of proliferation and di¡erentiation of cutaneous keratinocytes have been proposed (Pillai and Bikle, 1992; Cook et al, 1995) . In particular, P2X 5 receptors are expressed on cells undergoing proliferation and di¡erentiation, while P2X 7 receptors are associated with keratinized dead cells (Gr˛schel-Stewart et al, 1999) . P2Y 2 receptors, found in the basal layer of normal epidermis, are claimed to be involved in keratinocyte proliferation (Dixon et al, 1999) . P2Y 1 receptors are thought to be mitogenic in vascular smooth muscle cells and endothelial cells (Burnstock, 2002) .
The epidermis is a multilayered squamous epithelium in which dividing basal cells withdraw from the cell cycle and progressively di¡erentiate as they are displaced towards the skin surface. Eventually the cells lose their nuclei and other organelles to become £attened squames, which are ¢nally shed from the surface as bags of cross-linked keratin ¢laments enclosed in a corni¢ed envelope (Leigh et al, 1994) . Keratinocytes can undergo apoptosis when stimulated by a variety of agents (McCall and Cohen, 1991 There is evidence that the normal di¡erentiation programme uses components of the apoptotic biochemical machinery to produce a corni¢ed cell and that these mechanisms are required for the normal loss of the nucleus. Indeed, di¡erentiating keratinocytes and apoptotic cells share features, such as DNA fragmentation (Polakowska et al, 1994) and caspase-3 expression (Weil et al, 1999) .
This study demonstrates the distribution of P2X and P2Y receptor subtypes in human epidermis for the ¢rst time. Functional studies were performed on primary cultures of human keratinocytes and on explanted rat skin, where P2 receptor subtype agonists and antagonists were applied to cultured keratinocytes or injected subcutaneously into the skin, respectively. We show that purinergic receptors on keratinocytes are functional and propose that these receptors are part of the normal homeostatic mechanisms controlling keratinocyte proliferation, di¡erentiation and death.
MATERIALS AND METHODS
Tissues Twenty-six samples of normal human skin were examined immunohistochemically in this study. Ethical Committee Approval was obtained to harvest human skin. Samples of postoperatively redundant skin from reduction mammoplasty, abdominoplasty, and from the leg were obtained. Neonatal skin samples came from preauricular skin tags and accessory digits. Tissue was frozen in isopentane precooled in liquid nitrogen. Blocks were sectioned at 10 mm on a cryostat (Reichert Jung CM1800), collected on gelatin-coated slides and air-dried at room temperature. The slides were stored at À201C.
Antibodies The immunogens used for production of polyclonal P2X 5 and P2X 7 antibodies were synthetic peptides corresponding to 15 receptor-type-speci¢c amino acids (AA) in the intracellular C-termini of the cloned rat and human P2X receptors, as described previously (Gr˛schel-Stewart et al, 1999 , Oglesby et al, 1999 . P2X 5 and P2X 7 antibodies (provided by Roche Bioscience, Palo Alto, California) were kept frozen at a stock concentration of 1 mg/ml. Polyclonal anti-P2Y 1 and P2Y 2 antibodies were obtained from Alomone Laboratories (Jerusalem, Israel) , and corresponded to the third extracellular loop of the P2Y 1 (AA 242^258) and P2Y 2 receptor (AA 227^244) and were kept frozen at a stock concentration of 0.6 mg/ml. Proliferating cell nuclear antigen (PCNA) is a marker for proliferation in human keratinocytes (Miyagawa et al, 1989) . Cytokeratin K10 and involucrin are markers for keratinocyte di¡erentiation (Eckert et al, 1997) . PCNA (monoclonal antiproliferating cell nuclear antigen, clone PC10, raised in mouse ascites £uid; Sigma, Poole, UK), cytokeratin K10 (BioGenex, San Ramon, California) and involucrin (Sigma) antibodies were raised in mouse. Ki-67 antigen is a marker for cell proliferation in normal human keratinocytes (Gerdes et al, 1991) . Active caspase-3 is part of the apoptotic machinery of the cell and is expressed in terminally di¡erentiating keratinocytes (Weil et al, 1999) . Ki-67 (DAKO, Denmark) and active caspase-3 (Abcam, Cambridge, UK) antibodies were both raised in rabbit.
Immunohistochemistry For immunostaining of cryostat sections, the avidin-biotin technique was used according to a revised protocol (Llewellyn-Smith et al, 1993) . Sections were ¢xed for 2 min in 4% formaldehyde in 0.1 M phosphate bu¡er, containing 0.2% of a saturated solution of picric acid (pH 7.4). Sections were immersed for 10 min in 50% methanol containing 0.4% hydrogen peroxide, followed by a 20 minute preincubation in 10% normal horse serum (NHS) in 0.1 M phosphate bu¡er, containing 0.05% merthiolate (Sigma). Sections were incubated with the primary antibodies diluted to 1:100 or 1:200 (in 10% NHS in PBS þ 2.5% NaCl) at 41C overnight. Sections were then incubated with biotinylated donkey antirabbit IgG (Jackson ImmunoResearch Laboratory, West Grove, Pennsylvania) diluted to 1:500 in 1% NHS in PBS for 30 min, followed by ExtrAvidin peroxidase conjugate (Sigma) diluted to 1:1000 in PBS for 30 min. After a wash step, a nickel-diaminobenzidine (DAB) enhancement technique was used to visualize the reaction product. Sections were washed three times with PBS after each of the above steps except for after preincubation with 10% NHS. After the last wash, sections were dehydrated twice in isopropanol and mounted with EUKITT (BDH Laboratory Supplies, Poole, UK).
For immuno£uorescent staining, sections were ¢xed, incubated with primary antibodies overnight, and then incubated with the secondary antibody as above. This was followed by Streptavidin-FITC (Amersham Life Science) diluted 1:200 in PBS-merthiolate for 1 h. Sections were washed in PBS and mounted in Citi£uor (Citi£uor Ltd, London, UK).
Control experiments were carried out with primary, secondary and tertiary antibodies omitted from the staining procedure or the primary antibodies preabsorbed with the corresponding peptides.
Double-labeling techniques
Double-labeling with P2X or P2Y receptor antibodies and either PCNA, cytokeratin K10, or involucrin. Sections were ¢xed, incubated with primary antibodies overnight and the secondary antibody as described above. 1:200 Streptavidin Texas red (Amersham International plc.) was applied for 1 h. Sections were preincubated for 30 min with 10% normal goat serum (NGS) and then incubated for 2 h with either: 1:1000 PCNA (Sigma); 1:50 mouse antihuman cytokeratin K10 (BioGenex); 1:50 mouse monoclonal anti-involucrin (Sigma). After a wash step, 1:200 goat antimouse FITC (Nordic Immunological Laboratories, Tilburg, the Netherlands) was applied for 1 h; sections were washed and mounted in Citi£uor.
Double-labeling with P2X or P2Y receptor antibodies and either Ki-67 antigen or antihuman caspase-3 Sections were incubated with primary and secondary antibodies as described above. 1:1500 ExtrAvidin peroxidase conjugate (Sigma) was applied for 1 h, tyramide ampli¢cation for 8 min (Tyramide Ampli¢cation Kit, NEN Life Science Products, Boston, MA) and then 1:200 Streptavidin Texas red for 10 min. Sections were washed three times in PBS after each of the above steps. Sections were preincubated for 20 min in 10% NGS and then incubated for 2 h with either 1:50 rabbit antihuman Ki-67 antigen (DAKO) or 1:50 rabbit antihuman active caspase-3 (Abcam). Sections were washed and incubated with 1:1000 Oregon-green-labeled goatantirabbit IgG (Jackson ImmunoResearch Laboratory) for 45 min. Sections were washed and mounted in Citi£uor.
Double-labeling with P2X 7 receptor antibodies andTdT-mediated dUTP nick end labeling (TUNEL) TUNEL identi¢es cells undergoing apoptosis by labeling nuclear DNA fragments that have been cleaved during apoptosis (Gavrieli et al, 1992) . TUNEL labeling was performed using a kit (Boehringer Mannheim, Germany). After overnight incubation with P2X 7 receptor antibody diluted to 1:200 as above, sections were washed in PBS and then incubated with the TUNEL reaction mixture for 1 h at 371C. As a negative control, sections were incubated with the TUNEL Label solution only. After further washes in PBS, sections were incubated for 1 h with 1:500 biotinylated donkey antirabbit antibody. Sections were washed in PBS and then incubated for 1 h with 1:200 Streptavidin Texas red. Sections were washed in PBS and mounted in Citi£uor.
Photography The results were photographed using a Zeiss Axioplan, high de¢nition light microscope (Oberkochen, Germany) mounted with a Leica DC 200 digital camera (Heerbrugg, Switzerland).
Human primary cultures of keratinocytes in low calcium medium Human keratinocyte primary cultures were grown from redundant skin of consenting patients under age 30, who had undergone prominent ear correction, breast reduction and abdominoplasty. Cultures were grown in the presence of irradiated 3T3 feeder cells (Rheinwald, 1980) . Keratinocytes at passage 0 were disaggregated via trypsin at approximately 70% con£uency and seeded (passage 1) into low calcium keratinocyte medium (200 ml MCDB 153 medium, 10 ml chelated fetal calf serum, 2 ml RM + medium, 2 ml penicillin/streptomycin mixture, 2 ml L-glutamine and ¢lter sterilized (0.2 mm) before use). Cells were media-changed at 24 h after passage to remove the nonadherent, dead keratinocytes and remaining feeder cells. At 48 h after passage, cells were disaggregated with trypsin/EDTA and seeded into 96 well plates at a density of 4 Â 10 5 cells/well in low calcium medium for use in the proliferation assay.
Proliferation assay Twenty-four hours after seeding into 96 well plates, medium was gently aspirated from culture wells and concentration ranges of P2 receptor subtype agonists and antagonists (obtained from Sigma) were applied to the keratinocytes, diluted in low calcium keratinocyte medium. These included ATP; uridine 5 0 -triphosphate (UTP), P2Y 2 receptor agonist (von Kˇgelgen and Wetter, 2000) ; adenosine 5 0 -0-(3-thiotriphosphate) (ATPgS), P2X 5 receptor agonist (Khakh et al, 2000) ); 2 0 -& 3 0 -0-(4 -Benzoyl-benzoyl) adenosine 5 0 -triphosphate (BzATP), P2X 7 receptor agonist (Khakh et al, 2001 ), 2-Methylthioadenosine 5 0 -diphosphate (2MeSADP), P2Y 1 receptor agonist (von Kˇgelgen and Wetter, 2000) and Suramin, a nonselective P2X and P2Y receptor antagonist (Ralevic and Burnstock, 1998) . The pH of the drug solutions made up in culture medium was 7.0.
Changes in cell number were quanti¢ed via a colorimetric assay using crystal violet (Gillies et al, 1986; Kueng et al, 1989 ) and read using a spectrophotometric plate reader (Model 550, Microplate Manager s 4.0 Bio-Rad Laboratories, Inc. Hercules, CA, USA) at 0, 24, 48 and 72 h after addition of drugs. For the colorimetric assay, a solution of 0.5 g crystal violet, 0.85 g NaCl, 5 ml 10% formal saline, 50 ml absolute ethanol, 45 ml distilled H 2 0 was used. Medium was gently aspirated from wells of a 96 well plate and 100 ml of the colorimetric assay mixture was added to each well and incubated at room temperature for 10 min. This mixture allowed simultaneous ¢xation of cells and penetration of the crystal violet dye into the cells. After washing three times in PBS, 33% acetic acid was used to elute color from cells and optical density was read at 595 nm using the spectrophotometric plate reader. Changes in cell number measured via the assay were validated at least once for each drug set by doing actual cell counts with a hemocytometer. To con¢rm that the optical density of the wells correlated with cell numbers, a control assay was performed for each experiment, where known numbers of cells were seeded in ascending seeding densities and the plate read as soon as cells had attached. Cell number versus. optical density was plotted. The R 2 value of the trend line was always 40.98 (data not shown).
Statistical analysis Each proliferation assay experiment was repeated an average of eight times, each with triplicate samples. Data analysis was performed using Microsoft Excel 97 and GraphPad Prism 3.0 software. One-way analysis of variance (ANOVA) and Bonferroni's multiple comparison test were carried out between groups.
Subcutaneous injection experiment Skin was harvested from the back of adult male Wistar rats and 0.1 ml of ATP, ATPgS, BzATP, UTP or 2MeSADP was injected subcutaneously into the dermis, using a 1-ml syringe and a 27G needle, at concentrations from 1 to 500 mM. Controls had 0.1 ml of saline injected in the same way. The area of the injection site was marked on the skin with a marker pen and the solution in¢ltrated subcutaneously to a diameter of about 0.5 cm around the injection site. The skin was then placed in Hank's balanced salt solution and kept at 41C for one hour, after which the tissue was frozen in isopentane precooled in liquid nitrogen. Blocks were sectioned at 10 mm on a cryostat (Reichert Jung CM1800) until the marked area indicating the injection site was visible. Sections were collected on gelatin-coated slides and air-dried at room temperature. The injection site was indicated by blue ink on unstained slides. The slides were stained with hematoxylin and eosin and compared to unstained serial sections to reveal the injection site. From previous work (Terenghi et al, 1994) , n¼ 6 was established as the minimum size per group to avoid interanimal and intersample variation in£uencing the outcome of the results. This group size ensured that the statistical signi¢cance is at the 5% level, with an 80% statistical power. Each drug set was therefore repeated in six di¡erent animals.
RESULTS
P2X 5 and P2X 7 receptors are expressed in human skin P2X 5 and P2X 7 receptor immunoreactivity was observed in the epidermal keratinocytes of all human skin samples. P2X 5 receptor staining was restricted to the ¢rst two viable layers of the epidermis, with very few stained cells in the stratum granulosum. No P2X 5 receptor staining was found in the stratum corneum. Higher magni¢cation revealed di¡erences in staining for this receptor between the stratum basale and the stratum spinosum in both intensity and subcellular distribution, with staining of the stratum basale appearing slightly less intense than that of the stratum spinosum (Fig 1a) . In addition, staining within the stratum spinosum was mainly in the cytoplasm and possibly the plasma membrane, but not in the nucleus, whereas in the stratum basale the majority of staining appeared to be in the plasma membrane. Furthermore, this staining of the stratum basale cell membranes appeared to be polarized, being mainly concentrated on the basal aspects of the cells that were associated with the basement membrane. P2X 7 receptor immunoreactivity was solely associated with cells and cell fragments within the stratum corneum (Fig 1b) , and were often seen to be nuclear or perinuclear.
Some di¡erences were noted in the pattern and intensity of staining among the di¡erent skin areas. In lower leg skin, there was strong immunostaining for P2X 5 receptors in all the cells of the stratum basale and stratum spinosum (Fig 1a) . In breast and abdominal skin, P2X 5 immunoreactivity was similar to that in the lower leg with strong P2X 5 receptor staining within the stratum basale and spinosum. However, in these tissues, the stratum granulosum showed more intense P2X 5 immunoreactivity and almost all of the cells in the stratum granulosum stained positive for the P2X 5 antibody.
In lower leg skin (Fig 1b) , corneocytes and cell fragments within the stratum corneum stained positively for P2X 7 . The staining was of high intensity compared to that seen in the other areas examined. For example, in breast skin, which is thin, the staining for P2X 7 receptors was at the junction between the stratum granulosum and the stratum corneum in an almost continuous thin line. There was little staining of the stratum corneum in breast skin compared to that seen in the lower leg, abdomen and thigh skin. In abdominal skin, the P2X 7 receptor staining was in an almost continuous line, and staining of the stratum corneum was patchy. In thigh skin, membrane fragments within the stratum corneum stained positively for P2X 7 receptors, which were also sometimes expressed on the outer surface of the stratum corneum. In leg skin, the epidermis was thicker and the zones of the epidermis were better de¢ned than in other regions of the skin; therefore this was used for further studies.
P2Y 1 and P2Y 2 receptors are expressed in human skin P2Y 1 (Fig 1e) and P2Y 2 receptors (Fig 1f) were expressed in normal human skin. P2Y 1 receptors were found in the basal layer of the epidermis. P2Y 2 receptors were also found in the basal layer of the epidermis, with some expression in the stratum spinosum.
Control immunostaining experiments Both the omission of the primary antibody and preabsorption with corresponding peptides were performed as controls. With immuno£uorescence staining, there was some nonspeci¢c immunostaining of nuclei within the stratum spinosum and granulosum when the primary antibody was omitted, but there was no immunoreaction when the secondary and tertiary antibodies were omitted. The immunoreaction was abolished after absorption of the P2X 5 (Fig 1c) or P2X 7 receptor antibodies (Fig 1d) with the corresponding peptides, con¢rming the speci¢city of the immunoreaction. The immunoreaction was signi¢cantly reduced after absorption of the P2Y 1 (Fig 1g) or P2Y 2 antibody (Fig 1h) with the corresponding peptide, with some nonspeci¢c staining of nuclei within the stratum spinosum and granulosum, con¢rming the speci¢city of the ¢ndings.
Cells positive for P2Y 1 and P2Y 2 receptors also express markers for cellular proliferation Neonatal skin was dual stained for Ki-67 and P2Y 1 receptors (Fig 2a) and PCNA and P2Y 2 receptors (Fig 2b) . The proliferation markers identi¢ed a proliferating subpopulation of basal and parabasal keratinocytes. Cells positive for these two markers were also positive for P2Y 1 and P2Y 2 receptors.
Cells positive for P2X 5 receptors also express markers for keratinocyte di¡erentiation Double-labeling of P2X 5 receptors with cytokeratin K10 (Fig 2c) or involucrin (Fig 2d) showed that P2X 5 receptors were expressed in di¡erentiating keratinocytes within the epidermis. Cytokeratin K10, an early marker of keratinocyte di¡erentiation was found in most suprabasal keratinocytes. The stratum basale stained only for P2X 5 receptors, indicating that no di¡erentiation was taking place in these cells. The colocalization of P2X 5 receptors and cytokeratin K10 appeared mainly in the cytoplasm of di¡erentiating cells within the stratum spinosum and partly in the stratum granulosum. Involucrin, a late marker of keratinocyte di¡erentiation was expressed from the upper stratum spinosum up to the stratum corneum. There was colocalization of P2X 5 receptors with involucrin within the cytoplasm of cells within the upper stratum spinosum, with a few cells double-labeling within the stratum granulosum.
Double-labeling of P2X 7 receptors with markers for apoptosis in human skin show colocalization The cell nuclei in the uppermost level of the stratum granulosum stained strongly positive for TUNEL (Fig 2e) and Caspase-3 (Fig 2f) . Double-staining of the P2X 7 receptor and TUNEL showed that there was some overlap of staining, but that TUNEL largely stained the cell nuclei of living cells undergoing apoptosis in the uppermost layer of the stratum granulosum, while P2X 7 immunostaining also stained the dead cells in the stratum corneum above. The negative control for TUNEL showed no reaction. Double labeling of P2X 7 receptors with anti-Caspase-3 showed colocalization within the stratum corneum (Fig 2f) .
Functional studies of primary keratinocyte cultures show that P2 agonists can alter cell number Readings were taken of changes in optical density of cells grown in 96 well plates at 0, 24, 48 and 72 h after drug application. The peak e¡ect of the drugs was seen at 48 h after application, after which the e¡ect decreased.
At 48 h after application of drugs to primary cultures of human keratinocytes, ATP (1^10 mM), UTP (100 mM) (po0.001) (Fig 3a) , and 2MeSADP (500 mM) (po0.05) (Fig 3b) caused an increase in keratinocyte cell number. Whereas ATP (100 mM) (po0.001), ATPgS 100^500 mM (po0.001) (Fig 3a) and BzATP (100^500 mM) (po0.001) (Fig 3c) caused a signi¢cant decrease in cell number. Suramin (Fig 3d) caused a signi¢cant block in the e¡ect of high dose ATP at 100 mM (po0.01) and 1 mM (po0.001).
Direct subcutaneous injection of purinergic receptor agonists results in changes in the morphology of the rat epidermis No change in the morphology or thickness of the epidermis was seen when 0.1 ml saline was injected subcutaneously into control skin (Fig 4a,b) . Subcutaneous injection of either 0.1 ml 10 mM ATP (Fig 4c,d) , or 100 mM UTP (Fig 4e) resulted in a thickening of the rat epidermis compared to control skin, in 6 out of 6 rats studied. Subcutaneous injection of 500 mM 2MeSADP (Fig 4f) caused an increase in thickness of the epidermis in 3 out of 6 rats, with 3 showing no change. 10 mM ATP caused a 3 -fold increase in the thickness of the epidermis (Fig 4d) , whereas 100 mM UTP caused a 2-fold increase in thickness (Fig 4g) . Both ATP and UTP increased the number of viable cell layers, with UTP causing a smaller increase in the stratum granulosum and stratum corneum. 2MeSADP also caused an increase in the number of viable cell layers (Fig 4h) .
Subcutaneous injection of 300 mM ATPgS (Fig 4i,k) caused a slight decrease in thickness of the epidermis in 3 out of 6 rats, with the remaining 3 preparations showing no change compared to control. Subcutaneous injection of 300 mM BzATP (Fig 4j) caused a decrease in thickness of the viable cell layers of the epidermis in 4 out of 6 rats studied (in 2 out of 6 there was no change). The thickness of the epidermis was almost halved and the cells of the stratum granulosum were £attened and thinner than in control skin (Fig 4l) . The concentration of 300 mM was chosen for ATPgS and BzATP because this represented the midpoint of the range of e¡ective concentrations used within human primary keratinocyte cultures.
DISCUSSION
Early papers suggested that extracellular ATP may be an important physiological regulator of epidermal growth and di¡erentia-tion acting through G protein-coupled P2Y receptors (Pillai and Bikle, 1992; Cook et al, 1995) . However, these studies were not in a position to detect the P2 receptor subtypes involved or to show their di¡erential localization within the epidermis. In this study, we have obtained direct evidence for the expression of P2X 5 , P2X 7 , P2Y 1 and P2Y 2 receptors in human keratinocytes, using immunohistochemistry and functional studies in vitro. Human epidermal keratinocytes in frozen sections of leg skin express P2X 5 , P2X 7 , P2Y 1 and P2Y 2 receptors. (a) P2X 5 receptor immunostaining was present in the stratum spinosum (SS) and to a lesser extent in the stratum basale (SB). Only a few cells in the stratum granulosum (SG) had positive staining, which was of much lower intensity. There was no staining in the stratum corneum (SC). Scale bar 15 mm. (b) P2X 7 receptor immunostaining was present in whole cell remnants and cell fragments within the stratum corneum and was often seen to be nuclear or peri-nuclear (arrows). . Double-labeling of P2Y 1 and P2Y 2 receptors with markers of proliferation show colocalization within a subpopulation of basal and parabasal keratinocytes. Double-labeling of P2X 5 receptors with markers of di¡erentiated keratinocytes show colocalization within the stratum spinosum, and double-labeling of P2X 7 receptors with markers of apoptosis in human leg skin show colocalization within the stratum corneum. (a) Ki-67 immunolabeling (a marker for proliferation) stained the nuclei (green) of a subpopulation of keratinocytes in the basal and parabasal layers of the epidermis. P2Y 1 receptor immunostaining (red) was found in the basal layer on cells also staining for Ki67. Scale bar 30 mm. (b) PCNA immuno-labeling (a marker for proliferation) stained the nuclei (green) of a subpopulation of keratinocytes. These nuclei were often distributed in clusters and found in the basal and parabasal layers of the epidermis. P2Y 2 receptor immunostaining (red) was also expressed in basal and parabasal epidermal cells. Scale bar 30 mm. (c) P2X 5 receptor immunostaining (red) showed overlap (yellow) with cytokeratin K10 (green), an early marker of keratinocyte di¡erentiation. P2X 5 receptors were present in the basal layer of the epidermis up to the mid-granular layer. Cytokeratin K10 was distributed in most suprabasal keratinocytes. The stratum basale stained only for P2X 5 receptors, indicating that no di¡erentiation was taking place in these cells. The colocalization of P2X 5 receptors and cytokeratin K10 appeared mainly in the cytoplasm of di¡erentiating cells within the stratum spinosum and partly in the stratum granulosum. Note that the stratum corneum also stained for cytokeratin K10, which labeled di¡erentiated keratinocytes, even in dying cells. Scale bar 30 mm. (d) P2X 5 receptor immunostaining (red) showed overlap (yellow) with involucrin (green). P2X 5 receptors were present in the basal layer of the epidermis up to the midgranular layer. Note that the pattern of staining with involucrin was similar to that seen with cytokeratin K10, except that cells from the stratum basale up to the midstratum spinosum were not labeled with involucrin, which is a late marker of keratinocyte di¡erentiation. Scale bar 30 mm. (e) TUNEL (green) labeled the nuclei of cells at the uppermost level of the stratum granulosum and P2X 7 antibody (red) mainly stained cell fragments within the stratum corneum. Scale bar 15 mm. (f) Anti-Caspase-3 (green) colocalized with areas of P2X 7 receptor immunostaining (red) both at the junction of the stratum granulosum and within the stratum corneum. Areas of colocalization were yellow. Note that the di¡erentiating keratinocytes in the upper stratum granulosum were also positive for anti-Caspase-3. Scale bar 15 mm.
P2Y 1 and P2Y 2 receptors show a strong immuno-positive signal in the basal layer of the epidermis. Some basal cells are stem cells, others are transit-amplifying cells (which can undergo a variable number of rounds of division before becoming postmitotic) and some are postmitotic cells that are poised to move into the suprabasal layers. We performed double-labeling of P2Y 1 and P2Y 2 receptors and keratinocyte proliferation markers Ki-67 and PCNA. This con¢rmed the presence of these P2Y 1 and P2Y 2 receptors in proliferating cells. We have shown that the P2Y 1 and P2Y 2 receptor selective agonists, 2MeSADP and UTP, respectively, can cause an increase in human keratinocyte number in vitro. Direct subcutaneous injection of UTP into rat skin also causes a two-fold increase in thickness of the epidermis. This suggests that these receptors are involved in keratinocyte proliferation. Since the e¡ect of 2MeSADP is weaker than that of UTP, it also suggests that P2Y 2 receptors may have a more significant role in this process. Previous work has localized P2Y 2 receptor mRNA in human epidermal basal cells via in situ hybridization (Dixon et al, 1999) . UTP has also been shown to cause proliferation in keratinocytes (Dixon et al, 1999) and HaCaT cells (Lee et al, 2001) .
In this study, we have also shown the distribution of P2X 5 receptors within human epidermis for the ¢rst time. These receptors are also expressed in the basal layer, but are expressed more strongly in the stratum spinosum and variably into the stratum granulosum. The position of the keratinocyte within the epidermis correlates with its state of di¡erentiation. Di¡eren-tiation of the basal keratinocyte results in a permanent loss of growth potential and the subsequent sequential expression of di¡erentiation markers. The ¢rst markers expressed are the two suprabasal keratins K1 and K10 (Schweizer and Winter, 1983; Eichner et al, 1986) followed by other proteins such as involucrin (Watt, 1983) , which is detected in the late stratum spinosum and in the stratum granulosum. Double-labeling of P2X 5 receptors with either cytokeratin K10 or involucrin was performed to demonstrate that P2X 5 receptors are expressed on di¡erentiating keratinocytes. There is a striking overlap of expression of P2X 5 receptors with keratin K10, an early di¡erentiation marker but much less overlap with involucrin, which is expressed later. P2X 5 receptors may be more likely to be involved in keratinocyte di¡erentiation because ATPgS, a potent P2X 5 receptor agonist, causes a signi¢cant decrease in cell number in culture. This may be because keratinocytes are withdrawing from the cell cycle and di¡erentiating. ATPa ì S may cause premature di¡erentiation of the upper layers of the epidermis in rat skin, reducing the number of viable cell layers after subcutaneous injection. There is also evidence from other tissues regarding the role of P2X 5 receptors. In fetal rat skeletal muscle, P2X 5 receptors are sequentially expressed during development (Ryten et al, 2001 ) and associated with di¡erentiating cells (Ryten et al, 2002) . P2X 5 receptors have also been implicated in the regulation of osteoblastic di¡erentiation and proliferation (Hoebertz et al, 2000) .
The colocalization of P2X 7 receptors with two di¡erent apoptosis markers, TUNEL, and anticaspase-3 in the stratum corneum is of particular interest. The P2X 7 receptor is unlike other P2X receptors because it is a bifunctional molecule that can be triggered to act as a channel permeable to small cations, or, on prolonged stimulation, form a cytolytic pore permeable to large hydrophilic molecules up to 900 Da (Surprenant et al, 1996) . The opening of this pore results in the increase in intracellular cytosolic free calcium ions. The P2X 7 receptor is involved in the induction of cell death (Zheng et al, 1991; Ferrari et al, 1996) . P2X 7 receptors are also found on dendritic cells, macrophages and microglial cells, where extracellular ATP can trigger apoptosis via these receptors and there is increasing evidence High power view of (a) taken from the region where saline was injected subcutaneously in control sections. Saline injection has not affected the thickness of the epidermis. Scale bar 20 mm (c) The epidermis was signi¢cantly thickened in the area of the injection site (arrow) of 10 mM ATP. The bar represents the area of the epidermis a¡ected by low dose ATP, which is much thicker than the surrounding una¡ected epidermis. Scale bar 375 mm. (d) High power view of (c) taken from the region where 10 mM ATP was injected subcutaneously. Note how the epidermis has increased in thickness three-fold compared to control. Scale bar 20 mm (e, f) Low power view of injection site of 100 mM UTP, and 500 mM 2MeSADP, respectively, showing that UTP and 2Me-SADP caused an increase in thickness of the epidermis at the injection site (arrow). Scale bar 375 mm (g) 100 mM UTP caused a two-fold increase in epidermis thickness compared to control. Scale bar 20 mm. (h) 500 mM 2MeSADP caused an increase in thickness of epidermis compared to control. (i, j) Low power view of injection site of 300 mM ATPa ì S and 300 mM BzATP, respectively, showing that the epidermis was reduced in thickness in the area of the injection site (arrow). Scale bar 375 mm. (k) 300 mM ATPa ì S reduced the thickness of the epidermis. Scale bar 20 mm. (l) 300 mM BzATP almost halved the thickness of the epidermis and the morphology of stratum granulosum cells was changed such that cells were much £atter and thinner compared to control. Scale bar 20 mm.
that this process is dependent on the caspase signaling cascade (Coutinho-Silva et al, 1999; Ferrari et al, 1999) .
Caspase-3 is considered an executioner caspase, which once activated will cleave a number of cellular substrates whose limited proteolysis is de¢nitive of apoptosis (Nicholson and Thornberry, 1997) . Caspase-3 is expressed in terminally di¡eren-tiating keratinocytes (Weil et al, 1999) and colocalized with P2X 7 receptors in the stratum corneum. During apoptosis, the nucleus condenses and DNA is fragmented by endonucleases, which can be detected by TdT-mediated dUTP nick end labeling (TUNEL). TUNEL-positive keratinocytes have been found in the upper regions of the granular layer of the epidermis, before corni¢cation (Polakowska et al, 1994; Tamada et al, 1994; Gandarillas et al, 1999) and were also associated with P2X 7 receptors. These markers suggest that part of the apoptotic machinery of the cell is activated during keratinocyte terminal di¡erentia-tion and that this activation may be required for the normal loss of the nucleus in corneocyte formation. Our study suggests that P2X 7 receptors are also likely to be part of that machinery.
We have shown that P2X 7 receptors on keratinocytes are functional, cell numbers are signi¢cantly reduced when stimulated with BzATP in culture, and subcutaneous injection of BzATP appears to cause premature di¡erentiation or death of the upper layers of the epidermis in rat, leaving behind one to two viable cell layers. If P2X 7 receptors are involved in the terminal di¡er-entiation programme, which ends in ''cell death''and formation of the keratinized anucleate corneocyte, then cells grown in culture may also die by this mechanism. ATP in high doses has a similar e¡ect to that of BzATP in culture and it is likely that ATP is stimulating P2X 7 receptors on keratinocytes. This has been demonstrated in other cell systems (North and Surprenant, 2000) , and we have shown that this e¡ect can be signi¢cantly blocked by suramin in culture. Suramin is a nonspeci¢c antagonist of P2X and P2Y receptors.
In summary, P2 purinergic receptor agonists alter keratinocyte cell numbers via several mechanisms, namely UTP and low concentrations of ATP cause an increase in cell number, probably via a direct proliferative e¡ect on basal cells via P2Y 2 receptors. 2MeSADP also leads to an increase in cell number, probably via P2Y 1 receptors in the basal layer. ATPgS results in a decrease in cell number because cells are lost from the cell cycle by being made to di¡erentiate via activation of P2X 5 receptors. BzATP and high concentrations of ATP decrease cell numbers via a direct e¡ect on P2X 7 receptors, which are known to be involved in mediating apoptosis and are likely to be part of the machinery of end-stage terminal di¡erentiation of keratinocytes.
